APHA
Back to Annual Meeting Page
 
American Public Health Association
133rd Annual Meeting & Exposition
December 10-14, 2005
Philadelphia, PA
APHA 2005
 
3211.0: Monday, December 12, 2005 - 12:30 PM

Abstract #116598

OSHA update on crystalline silica

Loretta D. Schuman, PhD, MS, Directorate of Standards and Guidance, Occupational Safety and Health Administration, 200 Constitution Avenue NW, Room N-3718, Washington, DC 20210, 202-693-2290, schuman.loretta@dol.gov

Over 2 million workers are exposed to crystalline silica in general, construction and maritime industries such as foundries, industries that have abrasive blasting operations, paint manufacture, glass and concrete product manufacture, brick-making, china and pottery manufacture, manufacture of plumbing fixtures, and many construction activities including highway repair, masonry, concrete work, rock drilling, and tuckpointing. The seriousness of the health hazards associated with silica exposure is demonstrated by the fatalities and disabling illnesses that continue to occur. Currently, 200 to 300 deaths per year are known to occur where silicosis is identified on death certificates as an underlying or contributing cause. Many cases are no doubt unascertained. In addition, the International Agency for Research on Cancer (IARC) has designated crystalline silica as a human carcinogen. Exposure has also been associated with renal and autoimmune diseases. OSHA has addressed this problem through a variety of non-regulatory approaches, including initiation of a Special Emphasis Program and dissemination of guidance information on its Web site. OSHA is considering a range of regulatory options to address the hazards of crystalline silica. An update of recent OSHA activities on crystalline silica will be provided.

Learning Objectives:

Presenting author's disclosure statement:

I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.

Occupational Respiratory Disease: Surveillance and Solutions

The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA